Immunogenicity and Safety of a DTPa-HBV-IPV/Hib Vaccine Given at 2, 3 and 4 Months of Age

Clinical trial NCT00376779 · COMPLETED

Trial details

NCT number: NCT00376779
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Acellular Pertussis Tetanus Diphtheria Hepatitis B Poliomyelitis Haemophilus Influenzae Type b

Start date: 2006-10-01
Primary completion: 2007-05-01
Enrollment: 450

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.